Henan Lihua Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDROCORTISONE USP, with a corresponding US DMF Number 28066.
Remarkably, this DMF maintains an Active status since its submission on February 28, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 07, 2016, and payment made on December 24, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II